Logo Asphalion


Although the microbiome has been the subject of intense research over recent decades, very few publications have addressed its potential role in HIV/AIDS.

Although the microbiome has been the subject of intense research over recent decades, very few publications have addressed its potential role in HIV/AIDS.
June 27, 2023

Today is World Microbiome Day. Microorganisms (also called microbes, including bacteria, fungi, viruses, archaea, etc.) are pretty much everywhere. Even though they are usually invisible to the naked eye, they live in and on plants, animals, water, soil, food and humans. Within each of those habitats, microorganisms form communities called ‘microbiomes’. Researchers are uncovering more and more about what they do, and why this is so important to maintain the balance and health of their environment

At Asphalion we are the regulatory partners of the “Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications, antimicrobial drug resistance, and unresponsiveness to therapeutic HIV-1 vaccination” (MISTRAL) project. Coordinated by IrsiCaixa, the project is being carried out in collaboration with ten other institutions from Spain, Denmark, the USA and Sweden, bringing together a team of world-class HIV and microbiome researchers and SMEs. The scientists are analysing the role of the intestinal microbiome in HIV infection with the objective of designing treatments to prevent HIV infection, reinforce the immune system, control the progression of the infection and improve the response to potential vaccinations against the virus.

For more details, you can check the project´s website:


For further information, you can contact us at: info@asphalion.com

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 847943

Search News & Events

  • Filter by category


Related news and events

In2Sight | 4th annual meeting 3RS congress

At ASPHALION, we are part of the IN2SIGHT consortium, an EU-funded project, and we are delighted to be currently participating in the 4th annual meeting

Course | Regulatory aspects of vaccine development

TRANSVAC2 supported innovation for both prophylactic and therapeutic vaccine development by providing high-quality technical services across four different service platforms: Technology (for process development and GMP production), Immunocorrelates & Systems Biology, Animal models, and support for Clinical Trials. TRANSVAC also offered training courses to provide fundamental and advanced knowledge on a wide-range of vaccine development-related topics.


A lot of things have happened during these past three months. We received an award from AEFI as most engaged Company with its employees’ traning;

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting